Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 97

1.

Isoquercitrin inhibits the progression of liver cancer in vivo and in vitro via the MAPK signalling pathway.

Huang G, Tang B, Tang K, Dong X, Deng J, Liao L, Liao Z, Yang H, He S.

Oncol Rep. 2014 May;31(5):2377-84. doi: 10.3892/or.2014.3099. Epub 2014 Mar 20.

PMID:
24676882
[PubMed - in process]
2.

Extracorporeal photophoresis: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2006;6(6):1-82. Epub 2006 Mar 1.

PMID:
23074497
[PubMed]
Free PMC Article
3.

Expression and clinical significance of HMGB1 in human liver cancer: Knockdown inhibits tumor growth and metastasis in vitro and in vivo.

Dong YD, Cui L, Peng CH, Cheng DF, Han BS, Huang F.

Oncol Rep. 2013 Jan;29(1):87-94. doi: 10.3892/or.2012.2070. Epub 2012 Oct 4.

PMID:
23042506
[PubMed - indexed for MEDLINE]
4.

PRSS3 promotes tumour growth and metastasis of human pancreatic cancer.

Jiang G, Cao F, Ren G, Gao D, Bhakta V, Zhang Y, Cao H, Dong Z, Zang W, Zhang S, Wong HH, Hiley C, Crnogorac-Jurcevic T, Lemoine NR, Wang Y.

Gut. 2010 Nov;59(11):1535-44. doi: 10.1136/gut.2009.200105.

PMID:
20947888
[PubMed - indexed for MEDLINE]
5.

Mesothelin enhances invasion of ovarian cancer by inducing MMP-7 through MAPK/ERK and JNK pathways.

Chang MC, Chen CA, Chen PJ, Chiang YC, Chen YL, Mao TL, Lin HW, Lin Chiang WH, Cheng WF.

Biochem J. 2012 Mar 1;442(2):293-302. doi: 10.1042/BJ20110282.

PMID:
21999204
[PubMed - indexed for MEDLINE]
Free Article
6.

Overview of resistance to systemic therapy in patients with breast cancer.

Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.

Adv Exp Med Biol. 2007;608:1-22. Review.

PMID:
17993229
[PubMed - indexed for MEDLINE]
7.

Isoquercitrin activates the AMP-activated protein kinase (AMPK) signal pathway in rat H4IIE cells.

Zhou J, Yoshitomi H, Liu T, Zhou B, Sun W, Qin L, Guo X, Huang L, Wu L, Gao M.

BMC Complement Altern Med. 2014 Feb 3;14:42. doi: 10.1186/1472-6882-14-42.

PMID:
24490657
[PubMed - in process]
Free PMC Article
8.

Upregulation of SATB1 promotes tumor growth and metastasis in liver cancer.

Tu W, Luo M, Wang Z, Yan W, Xia Y, Deng H, He J, Han P, Tian D.

Liver Int. 2012 Aug;32(7):1064-78. doi: 10.1111/j.1478-3231.2012.02815.x. Epub 2012 May 14.

PMID:
22583549
[PubMed - indexed for MEDLINE]
9.

INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.

[No authors listed]

Drugs R D. 2007;8(3):176-87. Review.

PMID:
17472413
[PubMed - indexed for MEDLINE]
10.

The mitogen-activated protein kinase kinase/extracellular signal-regulated kinase cascade activation is a key signalling pathway involved in the regulation of G(1) phase progression in proliferating hepatocytes.

Talarmin H, Rescan C, Cariou S, Glaise D, Zanninelli G, Bilodeau M, Loyer P, Guguen-Guillouzo C, Baffet G.

Mol Cell Biol. 1999 Sep;19(9):6003-11.

PMID:
10454547
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Targeting the oncogenic protein kinase Ciota signalling pathway for the treatment of cancer.

Fields AP, Frederick LA, Regala RP.

Biochem Soc Trans. 2007 Nov;35(Pt 5):996-1000. Review.

PMID:
17956262
[PubMed - indexed for MEDLINE]
13.

Differential involvement of gp130 signalling pathways in modulating tobacco carcinogen-induced lung tumourigenesis.

Miller A, Brooks GD, McLeod L, Ruwanpura S, Jenkins BJ.

Oncogene. 2014 Apr 14;0. doi: 10.1038/onc.2014.99. [Epub ahead of print]

PMID:
24727895
[PubMed - as supplied by publisher]
14.

Inhibitors of Raf kinase activity block growth of thyroid cancer cells with RET/PTC or BRAF mutations in vitro and in vivo.

Ouyang B, Knauf JA, Smith EP, Zhang L, Ramsey T, Yusuff N, Batt D, Fagin JA.

Clin Cancer Res. 2006 Mar 15;12(6):1785-93.

PMID:
16551863
[PubMed - indexed for MEDLINE]
Free Article
15.

A phase I/II study of hepatic artery infusion with wtp53-CMV-Ad in metastatic malignant liver tumours.

Habib NA, Hodgson HJ, Lemoine N, Pignatelli M.

Hum Gene Ther. 1999 Aug 10;10(12):2019-34.

PMID:
10466636
[PubMed - indexed for MEDLINE]
16.

In vitro and in vivo anticarcinogenic effects of RNase MC2, a ribonuclease isolated from dietary bitter gourd, toward human liver cancer cells.

Fang EF, Zhang CZ, Zhang L, Fong WP, Ng TB.

Int J Biochem Cell Biol. 2012 Aug;44(8):1351-60. doi: 10.1016/j.biocel.2012.04.013. Epub 2012 Apr 24.

PMID:
22554586
[PubMed - indexed for MEDLINE]
17.

Huang-lian-jie-du-tang, a traditional Chinese medicine prescription, induces cell-cycle arrest and apoptosis in human liver cancer cells in vitro and in vivo.

Hsu YL, Kuo PL, Tzeng TF, Sung SC, Yen MH, Lin LT, Lin CC.

J Gastroenterol Hepatol. 2008 Jul;23(7 Pt 2):e290-9. doi: 10.1111/j.1440-1746.2008.05390.x. Epub 2008 Jun 3.

PMID:
18522681
[PubMed - indexed for MEDLINE]
18.

ZD6474, a dual tyrosine kinase inhibitor of EGFR and VEGFR-2, inhibits MAPK/ERK and AKT/PI3-K and induces apoptosis in breast cancer cells.

Sarkar S, Mazumdar A, Dash R, Sarkar D, Fisher PB, Mandal M.

Cancer Biol Ther. 2010 Apr 15;9(8):592-603. Epub 2010 Apr 4.

PMID:
20139705
[PubMed - indexed for MEDLINE]
Free Article
19.

Evodiamine induces apoptosis and inhibits metastasis in MDA‑MB-231 human breast cancer cells in vitro and in vivo.

Du J, Wang XF, Zhou QM, Zhang TL, Lu YY, Zhang H, Su SB.

Oncol Rep. 2013 Aug;30(2):685-94. doi: 10.3892/or.2013.2498. Epub 2013 May 27.

PMID:
23708383
[PubMed - indexed for MEDLINE]
20.

The clinical effectiveness and cost-effectiveness of ablative therapies in the management of liver metastases: systematic review and economic evaluation.

Loveman E, Jones J, Clegg AJ, Picot J, Colquitt JL, Mendes D, Breen DJ, Moore E, George S, Poston G, Cunningham D, Ruers T, Primrose J.

Health Technol Assess. 2014 Jan;18(7):vii-viii, 1-283. doi: 10.3310/hta18070.

PMID:
24484609
[PubMed - in process]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk